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Abstract
Background: We have previously shown that the enterotoxin SigA which resides on the she pathogenicity island (PAI) of S.
flexneri 2a is an autonomously secreted serine protease capable of degrading casein. We have also demonstrated that SigA
is cytopathic for HEp-2 cells and plays a role in the intestinal fluid accumulation associated with S. flexneri infections.
Methods/Principal Findings: In this work we show that SigA binds specifically to HEp-2 cells and degrades recombinant
human aII spectrin (a-fodrin) in vitro, suggesting that the cytotoxic and enterotoxic effects mediated by SigA are likely
associated with the degradation of epithelial fodrin. Consistent with our data, this study also demonstrates that SigA cleaves
intracellular fodrin in situ, causing its redistribution within cells. These results strongly implicate SigA in altering the
cytoskeleton during the pathogenesis of shigellosis. On the basis of these findings, cleavage of fodrin is a novel mechanism
of cellular intoxication for a Shigella toxin. Furthermore, information regarding immunogenicity to SigA in infected patients
is lacking. We studied the immune response of SigA from day 28 post-challenge serum of one volunteer from S. flexneri 2a
challenge studies. Our results demonstrate that SigA is immunogenic following infection with S. flexneri 2a.
Conclusions: This work shows that SigA binds to epithelial HEp-2 cells as well as being able to induce fodrin degradation in
vitro and in situ, further extending its documented role in the pathogenesis of Shigella infections.
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Introduction
Enteric infections are a major cause of morbidity and mortality
worldwide. Shigella infections alone result in over a million deaths
annually [1]. Infections with Shigella typically commence with
watery diarrhea often progressing to a bloody, mucoid diarrhea
characteristic of bacillary dysentery. Most of the virulence genes
that have been studied are involved in the ability of Shigella spp. to
invade the colonic epithelium and spread from cell to cell, leading
eventually to inflammation, ulceration and bloody diarrhea [2,3].
These genes are encoded on large, closely related, laterally
acquired virulence plasmids found in all Shigella spp. and in related
enteroinvasive E. coli (EIEC) [4].
At least five autotransporters have been identified in S. flexneri.
The autotransporter proteins of Gram-negative bacteria form a
family of proteins that share a common mechanism for
autonomous secretion. All such proteins possess an N-terminal
signal sequence for secretion across the inner membrane, a
secreted mature protein referred to as the passenger or functional
domain and a dedicated C-terminal domain which forms an
amphipathic b-barrel pore that allows passage of the functional
domain across the outer membrane. Exported proteins may
remain tethered to the cell surface or be released from the cell by
proteolytic cleavage [5]. Members of a subfamily known as
SPATE (serine protease autotransporters of Enterobacteriaceae)
possess a highly conserved serine protease motif [5], although
not all autotransporters are proteases [6]. SepA (SPATE) is borne
on the large virulence plasmid and is believed to play a role in
tissue invasion [7]. VirG/IcsA plays a critical role in the
recruitment and polymerisation of actin, thus allowing intra- and
intercellular spread [3]. Pic (SPATE) is able to cleave mucin and
human complement and a pic mutant is less inflammatory in
ligated ileal loops [8]. Sap [9], a homologue of Ag43 in E. coli [8],
is a phase-variable protein that mediates biofilm formation in S.
flexneri (H. Sakellaris, personal communication).
The sigA gene, which is carried on the she PAI of S. flexneri 2a,
encodes a 140 kDa protein which is autonomously secreted from
the cell as a 103 kDa processed form. Similar processing occurs in
E. coli clones harbouring sigA [10]. SigA is a temperature-regulated
serine protease capable of degrading casein; it shows no proteolytic
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bacterial cells transiently expressing SigA on the surface
agglutinate erythrocytes (K. Al-Hasani, unpublished data), indi-
cating a cell-binding activity that may be related to its role in
pathogenesis. We have shown that SigA is cytopathic for HEp-2
cells, inducing morphological changes similar to, but less
pronounced than, those induced by Pet, a related autotransporter
toxin in enteroaggregative E. coli. SigA causes a ‘‘rounding up’’ of
HEp-2 cells, consistent with disruption of the cytoskeleton, causing
a loss in the integrity of the cell monolayer [10]. In contrast, SepA
and Pic from S. flexneri 2a induced no morphological changes on
cell monolayers [11]. We have also demonstrated that SigA plays a
role in the intestinal fluid accumulation associated with S. flexneri
infections; a sigA mutant induced 30% less fluid accumulation in
ligated rabbit ileal loops than its wild type parent [10]. The
mechanism by which this occurs is unknown, but is likely to be
related to the cytopathic effect of SigA on epithelial cells. The Pet
toxin which shares 58% identity with SigA, degrades components
of the cytoskeleton, fodrin (spectrin analog)/spectrin, in HEp-2
cells and erythrocytes respectively [12]. Based on the similarities in
sequence and action of SigA to Pet, it is likely that SigA acts on the
same cellular substrate. In agreement with this hypothesis, this
work shows that SigA binds to epithelial HEp-2 cells as well as
being able to induce fodrin degradation in vitro and in situ, further
extending its documented role in virulence.
Materials and Methods
Ethics statement
Animal experimentation was approved by the Monash
University School of Biomedical Sciences Animal Ethics Com-
mittee. All protocols involving human studies were approved by
the University of Maryland Institutional Review Board (IRB) and
Good Clinical Practices (GCP) were followed. Informed written
consent was obtained from volunteers.
Bacterial plasmids, and media
The bacterial plasmids used in this study, pPBA1100 (vector only),
pSBA479 (pPBA1100 harbouring the complete sigA gene), and
pSBA493 (sigA mutant) were described previously [10]. Clone 18531
contains bp 2531–4689 of human aII spectrin was kindly provided by
Paul A. Stabatch [13], cloned into the EcoRI site of the inducible
bacterial expression vector pGEX-3X (Pharmacia, Uppsala, Sweden).
Escherichia coli DH5a and BL-21 were grown in either Luria Bertani
(LB) or 2xYT medium at 37uC with aeration. When antibiotic
selection was necessary, the growth medium was supplemented with
ampicillin (100 mg/ml), kanamycin (50 mg/ml), tetracycline (10 mg/
ml), streptomycin (25 mg/ml), or spectinomycin (25 mg/ml).
Protein purification and analysis
Bacteria containing pPBA1100, pSBA479 or pSBA493 were
grown in 3 ml 2xTY with kanamycin at 37uC for 16 h. Broth
cultures were diluted 1:100 in fresh medium and grown at 37uCt o
an absorbance at 600 nm of 0.5 (approximately 3.5 h), and then
were induced for 1 to 3 h with isopropyl-b-D-thiogalactopyranoside
(IPTG). The supernatants were obtained by centrifugation at 8,500
6g for 22 min, and then were filtered through 0.22-mm-pore-size
membrane filters (Corning, Cambridge, Mass.) and concentrated
100-fold in an ultrafree centrifugal filter device with a 50-kDa cutoff
(Millipore, Bedford, Mass.). Concentrated proteins were quantified
by the Bradford method, aliquoted and stored at -20uC. Proteins
were also analyzed by sodium dodecyl sulfate (SDS-PAGE).
GST-fodrin was prepared as described previously [13] with
some modifications. Briefly, overnight bacterial culture of clone
18531 was diluted 1:100 in fresh medium, grown for 1 h, and then
induced for 1–3 h with IPTG before harvesting by centrifugation.
Lysis was achieved by sonication, to which Glutathione Sepharose
4B beads (Pharmacia) were added to the soluble fraction for
affinity absorption at 4uC for 1 h, centrifuged for 3 min and
washed three times with 1.5 ml of phosphate-buffered saline
pH 7.2 (PBS). The pellet was then resuspended in 250 ml5 0m M
Tris-HCl, pH 9.6, containing 10 mM reduced glutathione.
Tissue culture assay
For all experiments, concentrated proteins were diluted into
Minimum Eagle’s Essential Medium (MEM), without serum, to a
final volume of 300 ml per well (for eight-well LabTek slides). The
cells were treated with either SigA (56 mg/ml) or equal volumes of
concentrated supernatants from E. coli containing DSigA
(pSBA493) or the empty vector (pPBA1100) for 3 h in a
humidified atmosphere of 5% CO2–95% air at 37u C. The
medium was then aspirated and cells were washed twice with
MEM and once with PBS.
Immunostaining
Cells were fixed with 3% paraformaldehyde–PBS for 20 min,
washed, permeabilized by addition of 0.1% Triton X-100–PBS for
10 min, washed, blocked with 1% BSA-PBS for 20 min.
Immediately, the cells were incubated with anti-spectrin a II
antibody (Santa Cruz Biotech, Santa Cruz, Calif.) at 1:75 dilution
for 1 h. The antigen-antibody reaction was developed by using the
secondary antibody fluorescein-labeled donkey anti-goat IgG
(Rockland, Philadelphia, Pennsylvania) at 1:250 dilution for 1 h.
Finally the cells were stained with 0.05 mg/ml of TRITC-
phalloidin (Sigma Chemical) for 20 min. Slides were mounted
on Vectashield Mounting Medium covered with glass coverslips
and examined under a Leica TCS SP2 confocal microscope.
Binding assay
The binding assay for SigA was performed with HEp-2 cells.
HEp-2 cells were prepared by diluting to 19,000 cells/ml using a
hemocytometer to estimate cell density. 100 ml of cells were added
to each well of a 96 well tissue culture plate (Cluster
96, Costar) and
incubated overnight at 37uCi n5 %C O 2. Wells containing sub-
confluent cells and wells not containing cells (used as a negative
control) were washed three times for 5 min, and blocked for
30 min with TBS-Tween and 1% BSA. Wells were washed three
times for 5 min and SigA protein was added in 50 ml or 100 ml
volumes and incubated for 2 h. Excess protein was washed off
(365 min) and 100 ml of 1 x sample buffer was added to solubilize
the protein. The tissue culture tray was then wrapped in cling film
and boiled for 5 min. All washes and incubations were carried out
on a shaker at room temperature.
Degradation assay
Ten microliters (1 mg) of purified GST-fodrin were mixed with
equal volumes of 2x digestion buffer (0.3 mM CaCl2, 10 mM
DTT) containing 2 mg of SigA. Reactions were carried out at 37uC
at different time points and stopped by the addition of 2x SDS
sample buffer. Samples were analyzed by SDS-PAGE. To inhibit
the activity of SigA, SigA was preincubated for 30 min at 37uC
with 2 mM phenylmethylsulfonyl fluoride (PMSF).
Immunoblot analyses
Protein samples were analyzed by SDS-PAGE [14], and
proteins were either stained with Coomassie blue or transferred
onto Immobilon
TM membranes (Millipore) as described by
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the membranes were probed with primary rabbit anti-SigA
polyclonal antiserum (diluted 1:2000) [10] and then with a
peroxidase-conjugated anti-rabbit IgG (diluted 1:5000) as the
secondary antibody (Chemicon International Inc., Temecula, CA).
Bound antibody was detected by chemiluminescence reagents
(Amersham Bioscience). The proteins from the degradation assays
were probed with anti-GST rabbit polyclonal serum (diluted
1:500), kindly supplied by Lev Katz, Monash University, to detect
GST-fodrin. A peroxidase-conjugated anti-rabbit IgG antibody
(diluted 1:500) was used as the secondary antibody (Chemicon
InternationalInc., Temecula, CA). 4-chloro-1-napthol was used as
the chromogenic detection reagent.
A serum sample collected from a Center for Vaccine
Development (CVD) volunteer who participated in S. flexneria 2a
challenge studies was the generous gift of Myron Levine
(University of Maryland, USA). Detection of SigA-specific
antibodies in human serum was evaluated by immunoblot analysis.
An immunblot of concentrated supernatant extracts from S. flexneri
2a YSH6000T (wild-type parent), SBA1356 (DsepA-Dshe) and
SBA1359 (DsigA-DsepA-Dshe) was probed with the human serum
sample (diluted 1:600), and then with a peroxidase-conjugated
anti-human Ig (diluted 1:800) as the secondary antibody
(Chemicon International Inc., Temecula, CA). These strains have
been described previously [10]. The presence of SigA was detected
using the same procedure as that used to detect GST-fodrin.
Results and Discussion
In this study, we sought to further characterize the biological
role of SigA in the pathogenesis of shigellosis by investigating the
nature of its interaction with the mammalian cell. SigA was
incubated with HEp-2 cells, and bound SigA was detected by
Western blotting using specific rabbit antiserum to SigA (Fig. 1,
lane 1). SigA incubated in tissue culture wells in the absence of
HEp-2 cells (Fig. 1, lane 2) was included as a control for non-
specific binding to the tissue culture plate. No reaction band was
seen in HEp-2 cells in the absence of SigA (Fig. 2, lane 3). PMSF-
treated SigA bound equally well to HEp-2 cells, showing that
proteolytic activity is not essential for cell binding (data not shown).
This finding confirmed that the cell binding and the cytotoxic
properties of this bifunctional molecule are distinct. The absence
of correlation of the enzymatic activity of SigA with its binding
activity has been noted for another related SPATE autotranspor-
ter, Tsh [16]. Those observations demonstrated that the passenger
domain of Tsh is bifunctional, in that it exhibited both adhesive
and proteolytic properties that are almost independent of each
other.
To define the substrate specificity of SigA, we performed in vitro
degradation experiments using recombinant a-fodrin, as the
cloned fragment contains a protease hypersensitive region in the
centre of a-fodrin [17]. GST-fodrin (109 kDa) was exposed to
SigA protein preparation with or without PMSF. Western blot
analysis showed that SigA degrades recombinant human aII-
spectrin (a-fodrin) in vitro (Fig. 2), suggesting that the cytotoxic and
enterotoxic effects mediated by SigA are likely associated with the
degradation of epithelial cell fodrin. SigA protein preparations
pre-incubated with PMSF did not demonstrate proteolytic activity
for the recombinant GST-fodrin (Fig. 2, lane 6). The 72 kDa
subproduct was detected by the anti-GST antibody, indicating
that this fragment contains GST (27 kDa) and a a-fodrin fragment
of 45 kDa. These data suggest that degradation of a-fodrin by
SigA and Pet occurs at the same cleavage site within repeat 11 of
a-fodrin. We were unsuccessful in our attempt to confirm the
location of the cleavage by N-terminal amino acid sequencing of
the putative 37 kDa sub-product from recombinant a-fodrin, due
to our inability to visualize it by SDS-PAGE. We predict, however,
that it occurs in the protease hypersensitivity region between
M1198 and V1199 inside the calmodulin binding domain, based on
previous work on Pet by Canizalez-Roman and Navarro-Garcı ´a
[18]. Notably, complete degradation of recombinant a-fodrin was
not observed even following overnight incubation with SigA (data
not shown), whereas with Pet complete degradation of fodrin
occurred within 2 h [18]. As was reported previously [10], when
compared to SigA, purified Pet toxin, induced a more pronounced
level of toxicity which may result from the differences in their
abilities to degrade fodrin. The basis for this differential effect
Figure 1. SigA binds specifically to HEp-2 cells. HEp-2 cells were
incubated in the presence (lane 1) or absence (lane 3) of SigA and
washed to remove unbound SigA. Bound SigA was recovered by
treatment of HEp-2 cells with protein sample buffer and assayed by
Western analysis with anti-SigA antiserum. A control for non-specific
binding of SigA to the tissue culture plate was also included (lane 2).
Culture supernatants of E. coli either not expressing (lane 4) or
expressing (lane 5) SigA, indicate the position of SigA on the gel
(asterisk). The positions of standard molecular mass markers (kDa) are
shown on the right.
doi:10.1371/journal.pone.0008223.g001
Figure 2. Degradation of human a-fodrin by SigA. Purified GST-
fodrin was incubated with SigA (lanes 1, 2 and 3) or Pet positive control
(lanes 4, 5 and 6) for zero (lanes 1 and 4) or 6 h (lanes 2 and 5). Lanes 3
and 6 shows SigA or Pet, respectively, pre-treated with PMSF and
incubated with GST-fodrin for 6 h. The top arrow indicates the 109 kDa
GST-fodrin fusion protein and the 74 kDa subproduct of degradation is
indicated by the bottom arrow.
doi:10.1371/journal.pone.0008223.g002
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their binding affinities to fodrin.
It has been shown that Pet degrades fodrin, causing its
redistribution in HEp-2 cells. Since SigA has affinity for
recombinant a-fodrin, we investigated whether SigA was able to
induce fodrin redistribution. To address this issue, HEp-2 cells
were incubated with or without SigA or DSigA for 3 h, and the
actin cytoskeleton and a-fodrin were stained with rhodamine-
phalloidin and anti-a-fodrin antibodies and visualized by confocal
microscopy. Staining of control cells (treated with supernatants
from pPBA1100) with anti-fodrin antibodies revealed small green
fluorescent spots along the epithelial cell (Fig. 3C). In contrast, a
clear change in fodrin distribution was observed after 3 h of
exposure with SigA (Fig. 3A). Fodrin was redistributed to form
intracellular aggregates, which were located in membrane blebs,
an indication that it may serve as an important substrate for SigA
during the course of human infection. However, when cells were
treated with the supernatant extract from the DSigA mutant, this
characteristic redistribution was not observed and was comparable
to the untreated cells (Fig. 3B). It is of interest that EspC, a SPATE
autotransporter of EPEC, did not produce redistribution of fodrin
in epithelial cells, as SigA and Pet do, suggesting differences
among these closely related toxins [19]. These results do not
exclude the possibility that additional cellular subtrates for SigA
exist; thus the ability of SigA to proteolytically cleave other
substrates warrants further investigation.
There is limited information concerning the nature and extent
of the immune response to the SPATE family of autotransporters.
Figure 3. Effects of SigA on fodrin redistribution in epithelial cells. HEp-2 cells were treated for 3 h with supernatant from SigA clone (A), or
DSigA (B) or vector only used as a control (C). Cells were then fixed and stained with rhodamine-phalloidin, and anti-a-fodrin antibodies, and a
fluorescein-labeled secondary anti-goat antibody. Intracellular aggregates of fodrin are indicated by arrows.
doi:10.1371/journal.pone.0008223.g003
Figure 4. Antibody response against S. flexneri 2a SigA in a
human volunteer. Concentrated culture supernatant extracts were
separated by SDS-PAGE and immunoreacted with human post-
challenge serum. Lanes: 1, molecular mass markers (kDa); 2, supernatant
of S. flexneri 2a YSH6000T (parent strain); 3, supernatant of SBA1356
(sepA and she deficient double mutant); 4, supernatant of SBA1359
(sigA-sepA-she triple mutant). The arrowhead indicates the reactivity of
serum from a volunteer against the 103-kDa secreted SigA antigen.
doi:10.1371/journal.pone.0008223.g004
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to two serine protease autotransporters, Pet and Pic, during the
course of a natural EAEC infection in children [20]. To our
knowledge, nothing is known about the in vivo expression of SigA
during infection, and therefore, to gain a better understanding of
the expression of SigA in vivo, we examined the antibody response
against SigA with a volunteer infected with S. flexneri 2a.
Concentrated culture supernatant extracts from the parental
strain (S. flexneri 2a YSH6000T), SBA1356 (SepA and Pic deficient
double mutant; previously described [10]), and SBA1359 (SigA,
SepA and Pic triple mutant) were used in an immunoblot assay.
The serum showed reactivity against three major bands with
apparent molecular masses above 100 kDa, including native SigA
(Fig. 4, Lane 2). In contrast, these three immunoreactive bands
were not detected in the culture supernatant preparation of
SBA1359 (previously described) which has all known S. flexneri 2a
SPATE encoding genes (sigA, sepA and she) insertionally inactivated
(Fig. 4, Lane 4). In the culture supernatant of SBA1356, a sepA and
she defective strain, immunoreactivity with SigA was detected.
However, the two immunoreactive bands which we suspect
correspond to SepA and Pic (encoded by pic(she)) were absent.
Normal human serum used as a negative control did not react
against SigA (data not shown). To our knowledge, there are no
published studies reporting on human antibody recognition of
SepA. However, Pic from Enteroaggregative E. coli (EAEC) has
been shown to be immunogenic [20]. Overall, this observation
suggests the existence of antibodies against SigA, and possibly
against all three Shigella SPATES. This serological investigation
will provide the foundations for future work aimed at deciphering
in more detail the host immune response against SigA, so as to
eventually map the specific epitopes implicated in this induction as
a prerequisite to the development of vaccines against shigellosis.
Recently, Kotloff et al [21] inactivated the genes encoding the
Shigella enterotoxins (ShET1 and 2) present on the she PAI and on
the virulence plasmid respectively, and demonstrated in human
clinical trials using this live, attenuated oral Shigella vaccine, their
effectiveness in eliminating reactogenicity and reaching immune
response levels that are likely to translate into clinical protection.
This finding reinforces the need to comprehensively understand
the biological relevance of the she PAI in establishing disease, in
particular that of SigA, given the documented role of sigA. Taken
together, this study clearly extends and further substantiates the
role for SigA in the pathogenesis of Shigella infections.
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